Leap Therapeutics Inc

NASDAQ:LPTX   9:45:46 AM EDT
1.58
+0.01 (+0.64%)
Earnings Announcements

Leap Therapeutics Reports Qtrly Loss Per Share $0.09

Published: 03/12/2021 12:17 GMT
Leap Therapeutics Inc (LPTX) - Leap Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results.
Qtrly Loss per Share $0.09.
Q4 Earnings per Share View $-0.09 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.29 Million
Adjusted EPS is expected to be -$0.12

Next Quarter Revenue Guidance is expected to be $1.79 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.